GDPR: The Implications for Clinical Development
Eight months in, Nigel Hughes, Scientific Director JCI-PDR, Janssen, examines the ramifications of GDPR on...
New Data Suggest HCV Remains a Problem in the US
Topias Lemetyinen, Senior Epidemiologist, GlobalData, explains why HCV continues to be an enduring issue in...
Industry Viewpoints: The Challenges of Clinical Data Management
In this Industry Viewpoint, Sarah Fal speaks to Kumar Komuravelli, Mallinckrodt Pharmaceuticals, on the arising...
How Can Blockchain Disrupt the Pharma Industry?
CTA Editor Henry Kerali explores what impact blockchain could have on clinical research
Expert Insights: Moderna Therapeutics Barrels Ahead Towards Historic IPO
Paul Jeng, PhD, Infectious Diseases Analyst, GlobalData, analyzes Moderna Therapeutics’ growing stature as the young...
Industry Viewpoints: Leveraging eSource in Data Management
CTA’s Sarah Fal interviews Terry Katz, Merck Animal Health, on the latest clinical data management...
Perfect Communication? That’s an Oxymoron!
Audrey Hill, Senior Director, Data Management, Advaxis, Inc., explains the keys to clear communication in...
Enriched Evidence Generation: Linking Clinical Data, Registries and Patient-Reported Outcomes to Health Care Utilization
Eric Van Ganse, Manon Belhassen, PELyon, & Francois Gavini, Roche, explain how French national claims...
Expert Insights: Another Failure for BACE1 Drugs Raises Questions about Alzheimer’s Disease Treatments
Alessio Brunello, MSc, Neurology & Ophthalmology Analyst, GlobalData, explores the implications of Janssen’s decision to...
The Top 5: June 2018
CTA highlights the best articles from the month of June 2018